ダウニーカタログ

本文へジャンプ

フリーダイヤルでもお気軽に0120-22 55 66

お問い合わせ

フリーダイヤル0120-22 55 66

携帯電話からは
050-5577-5041

ホーム > Rakuten Direct プレスリリース > Kenko.com considers a new business aimed at reducing the drug lag

Download PDF ver. (PDF file)

Kenko.com, Inc. (Genri Goto, CEO)(TOKYO:3325), is an e-commerce (EC) company selling nutritional supplements, pharmaceutical products, and other products via the Internet. On March 26, we announced that we have begun studying the possibility of serving as a private import agent providing services to doctors who need pharmaceutical products that are difficult to utilize in Japan because they have not yet been approved here even though they are widely distributed throughout the world.

●Support doctors as a private import agent for pharmaceuticals that are difficult to obtain in Japan despite being used safely and effectively for treatment in many countries

The drug approval process in Japan takes a very long time. Consequently, even drugs approved and in safe and effective use in other countries may not be available in Japan as they have not yet been approved here. The end result of this situation is that doctors are forced to privately import drugs that they need to treat their patients.

With the objective of improving the circumstances caused by this drug lag* and achieving the appropriate and timely distribution in Japan of pharmaceuticals approved elsewhere in the world, Kenko.com has begun investigations concerning establishing a subsidiary company in the United States and using that company to offer private import agent services for drugs that doctors have judged necessary for patient treatment but that have not been approved in Japan.

●Strive to provide Japanese customers with advanced pharmaceutical services at the same level available in countries worldwide

Although we are already one of the largest health-related EC sites in Japan, Kenko.com last year began a global business initiative aimed at making us the number one health-related EC site in Asia and the entire world. As part of our efforts to contribute to the health of people everywhere, we are also moving forward with initiatives to also provide our Japanese customers with pharmaceutical services at the same high level available in other countries.

*Drug lag: This is the time lag that exists between the time that drugs are approved overseas and the time that are approved and become available in Japan. Compared to the United States and many countries in Europe, pharmaceutical approval time in Japan is remarkably long, creating the problem that doctors must rely upon private importing to obtain effective drugs approved abroad but unavailable here.

【Kenko.com profile】http://www.kenko.com/
Started in May 2000, Kenko.com is an EC site for health-related products (nutritional supplements, pharmaceutical products, healing products, etc.). The number of products handled is approximately 120,000 (as of March 2010). Listed on the Tokyo Stock Exchange Mothers section under the stock code 3325 in June 2004.

【Inquiries】Kenko.com, Inc./Public Relations Office (Rena Takasuga)
Tel:03-3584-4138  Mail:pr@kenko.com